|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Product development | |||||
| Selling, general, and administrative | |||||
| Loss on impairment | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other expenses (income): | |||||
| Interest income | |||||
| Interest expense | |||||
| Gain on debt extinguishment | |||||
| Gain on disposal of fixed assets | |||||
| Other income | |||||
| Other expenses | |||||
| Loss from operations before income taxes | |||||
| Provision for income taxes | |||||
| Net loss | |||||
| Net loss per common stock - basic and diluted | |||||
| Net loss, basic (in dollars per share) | |||||
| Net loss, diluted (in dollars per share) | |||||
| Weighted average shares of common stock outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...